Bristol Myers Squibb Announces Positive Topline Results of Phase 3 COMMANDS Trial
Neuro Central,
Reblozyl, the first erythroid maturation agent, met primary and key secondary endpoints in the first-line treatment of patients…
Reblozyl, the first erythroid maturation agent, met primary and key secondary endpoints in the first-line treatment of patients…
Submission based on results from Phase 2 BEYOND study of Reblozyl plus best supportive care in adults with NTD beta…
Results showed treatment with Reblozyl plus best supportive care improved anemia in 77% of patients compared to…
Nel mondo la talassemia colpisce circa il 7% della popolazione, e in Italia i pazienti che convivono con questa malattia sono…